These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1700309

  • 1. Actions of the phosphodiesterase inhibitor zardaverine on guinea-pig ventricular muscle.
    Galvan M, Schudt C.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):221-7. PubMed ID: 1700309
    [Abstract] [Full Text] [Related]

  • 2. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M, Sugawara H, Yoshimura A, Ogura A, Yoshioka K, Sakato M, Endoh M.
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [Abstract] [Full Text] [Related]

  • 3. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T, Gotanda K, Sasaki T, Shinbo A, Asano H, Miyazawa K, Miyasaka K.
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW, Torphy TJ.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle.
    Honerjäger P, Heiss A, Schäfer-Korting M, Schönsteiner G, Reiter M.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):259-69. PubMed ID: 6328334
    [Abstract] [Full Text] [Related]

  • 10. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C, Meyer W, Scholz H, Starbatty J.
    Arzneimittelforschung; 1985 Mar; 35(11):1668-73. PubMed ID: 2418846
    [Abstract] [Full Text] [Related]

  • 11. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
    Scholtysik G, Salzmann R, Berthold R, Herzig JW, Quast U, Markstein R.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):316-25. PubMed ID: 2991779
    [Abstract] [Full Text] [Related]

  • 12. Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
    Matsui K, Kiyosue T, Wang JC, Dohi K, Arita M.
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):105-13. PubMed ID: 10372225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Brunkhorst D, v der Leyen H, Meyer W, Nigbur R, Schmidt-Schumacher C, Scholz H.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
    [Abstract] [Full Text] [Related]

  • 15. Interaction of phosphodiesterase inhibitor and isoproterenol in human and guinea-pig ventricular tissues and myocytes.
    Cheng PY, Lin CI, Lee FY, Chen YC, Lu HH.
    Chin J Physiol; 1995 May; 38(3):185-91. PubMed ID: 8846728
    [Abstract] [Full Text] [Related]

  • 16. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
    Beier N, Harting J, Jonas R, Klockow M, Lues I, Haeusler G.
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
    [Abstract] [Full Text] [Related]

  • 17. Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues.
    Korth M, Engels J, Schäfer-Korting M.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):166-75. PubMed ID: 2436059
    [Abstract] [Full Text] [Related]

  • 18. Imidazopyridines: roles of pyridine nitrogen position and methylsulfinyl oxygen for in vitro positive inotropic mechanism and chronotropic activity.
    Honerjäger P, Klockow M, Schönsteiner G, Jonas R.
    J Cardiovasc Pharmacol; 1989 May; 13(5):673-81. PubMed ID: 2472514
    [Abstract] [Full Text] [Related]

  • 19. The inotropic mechanism of the phosphodiesterase inhibitor OPC 3911 alone and in combination with rolipram, studied in papillary muscles of ferret and guinea-pig and isolated myocytes of guinea-pig ventricular muscle.
    Mörner SE, Arlock P, Lindgren S.
    Acta Physiol Scand; 1994 Mar; 150(3):325-34. PubMed ID: 8010139
    [Abstract] [Full Text] [Related]

  • 20. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.